Ionis Pharmaceuticals Inc at Piper Sandler Healthcare Conference (Virtual) Transcript
Hi there, everyone. My name is Tyler Van Buren, I'm a senior biotech analyst at Piper Sandler. Welcome to Piper's 32nd Annual Healthcare Conference. As this is our first time with a virtual format, we appreciate you all logging in. For this session, we're very pleased to have Ionis Pharmaceuticals here with us. And from Ionis, we have Brett Monia, the Chief Executive Officer; and Beth Hougen, the Chief Financial Officer.
So I figured we could start with a brief state of the union of the company and the description of the science behind the drugs for those who are less familiar, which by now, I'm sure it's not many. But also, it would be helpful to explain why you guys are so committed to the antisense technology and what indications it could be used for.
Sure. Thank you very much, Tyler, and thank you for the invitation. It's a pleasure to be here. So yes, we're very excited
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |